Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

End of Year Sale!
Grab Our Small Cap Recommendation
Service at a 60% Discount




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian equity markets continue to slide
Fri, 2 Aug 01:30 pm

Backed by persistent selling activity, Indian equity markets continued to trade weak during the post noon trading session. Barring stocks from Consumer durables and IT sector all the sectoral indicies are trading in red. Stocks from metal and PSU sectors are witnessing maximum selling pressures.

BSE-Sensex is down by 117 points and NSE-Nifty is trading down by 38 points. While BSE Mid Cap is trading down by 0.47%, BSE Small Cap index is trading down by 0.83%. The rupee is trading at 60.78 to the US dollar.

Majority of automobile stocks are trading in the red with Escorts and Force Motors being the biggest losers. Ashok Leyland and Maruti Suzuki are among the few stocks trading in the green. With economic conditions remaining gloomy, automobile manufacturers continued to face the brunt of falling sales. As per a leading financial daily, Bajaj Auto clocked a 20% YoY fall in motorcycle sales to 2,46, 828 units in July. Even its exports were down by 12% YoY for the month. However, sale of commercial vehicles fell by a subdued 2% to 34,449 units in July. For the period April-July 2013, cumulative sales of motorcycles were down by 14% YoY to 11,06,979 units whereas exports declined by 13% to 4,72,586 units. However, sales of commercial vehicles surged by 17% YoY to 1,53,623 units for the period April-July 2013. Bajaj Auto stock is currently trading down by 1.2%.

Most of the Indian pharma stocks are trading in the red with Wockhardt Ltd and Fresenius Kabi being the leading losers. As per the financial daily, Glenmark pharma declared its June 2013 quarter results. Topline grew by 19% YoY during the quarter led by growth in both its specialty and generics businesses. The specialty segment increased by 21%, due healthy growth in its domestic, Rest of the world and Latin America segments. However Europe witnessed decline of 3% YoY for the said period. In the generic segment growth was led by good performance in its API (Active pharmaceuticals segment) which grew by 26.5%. The US segment grew by 13% YoY, during the year. The Operating margins were up by by 4.1% leading to a 50.1% YoY growth in operating profits. Bottomline growth jumped by 64.3% YoY during 1QFY14 with the net margins also improving by 2.9%. Glenmark was trading down by 2.6%

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets continue to slide". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.